Obesity drugs may be sold at just $149 a month, get covered under Medicare under a reported White House deal in the works

The White House is close to announcing a deal with drugmakers Eli Lilly and Novo Nordisk that would cut the price of obesity drugs to $149 per month in some cases and extend coverage to certain Medicare and Medicaid beneficiaries, according to media reports Tuesday.Weiter zum vollständigen Artikel bei MarketWatch Weiter zum vollständigen Artikel bei MarketWatch